Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome

被引:92
|
作者
Dlugosz, A. [1 ,2 ]
Nowak, P. [3 ]
D'Amato, M. [4 ]
Mohammadian Kermani, G. [1 ,2 ]
Nystrom, J. [5 ]
Abdurahman, S. [6 ]
Lindberg, G. [1 ,2 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Med, SE-14186 Stockholm, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Ctr Digest Dis, SE-14186 Stockholm, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, SE-14186 Stockholm, Sweden
[4] Karolinska Univ Hosp, Karolinska Inst, Dept Biosci & Nutr, SE-14186 Stockholm, Sweden
[5] Karolinska Univ Hosp, Karolinska Inst, Div Clin Microbiol, Dept Lab Med, SE-14186 Stockholm, Sweden
[6] Univ Orebro, Orebro Life Sci Ctr, Dept Sci & Technol, SE-70182 Orebro, Sweden
来源
NEUROGASTROENTEROLOGY AND MOTILITY | 2015年 / 27卷 / 12期
关键词
Flagellin; irritable bowel syndrome; lipopolysaccharide; soluble CD14; toll-like receptors; BACTERIAL TRANSLOCATION; CROHNS-DISEASE; SOLUBLE CD14; BINDING PROTEIN; INCREASED IGA; FLAGELLIN; POLYMORPHISMS; ACTIVATION; MARKERS; GUT;
D O I
10.1111/nmo.12670
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundInnate immune responses to conserved microbial products such as lipopolysaccharide (LPS) and flagellin are likely important in microbial-host interactions and intestinal homeostasis. We hypothesized that bacterial translocation and activation of mucosal immunity against common microbial antigens might be involved in the development of irritable bowel syndrome (IBS). We therefore compared serum levels of LPS, soluble CD14 (sCD14), and flagellin antibodies between patients with different subtypes of IBS and healthy controls. MethodsWe analyzed serum obtained from 88 patients (74 females) aged 19(43)-73 years and 106 healthy volunteers (77 females) aged 19(38)-62 years. Diarrhea-predominant IBS (D-IBS) was present in 32 patients (36%), 23 patients (26%) had constipation-predominant IBS (C-IBS), and 33 patients (38%) had A-IBS. We used ELISA for sCD14 and antiflagellin immunoglobulin G and limulus amebocyte assay for LPS. Abdominal symptoms and psychiatric comorbidities were assessed using validated questionnaires. Key ResultsWe found a significantly higher serum level of LPS in patients with D-IBS compared to controls (p = 0.0155). The level of antibodies to flagellin was higher in patients with IBS than in controls (mainly driven by higher levels in D-IBS, p = 0.0018). The levels of sCD14 were lower in D-IBS patients compared to controls (p = 0.0498). We found a weak, but significant correlation between the levels of antiflagellin antibodies and anxiety among IBS patients ( = 0.38; p = 0.0045). Conclusions & InferencesOur results support the concept that immune reactivity to luminal antigens may have a role in the development of D-IBS. The serum level of antiflagellin antibodies was found to correlate with patients' self-reported anxiety score.
引用
收藏
页码:1747 / 1754
页数:8
相关论文
共 50 条
  • [21] GUT MICROBIOTA INDUCE THE INCREASED EXCRETION OF BILE ACIDS IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Zhao, Ling
    Yang, Wei
    Lu, Lin
    Zhai, Lixiang
    Zhong, Linda
    Lam, Wai-ching
    Cheng, Chung-wah
    Bian, Zhao-xiang
    GASTROENTEROLOGY, 2019, 156 (06) : S198 - S198
  • [22] Ultrastructure of intestinal mucosa in diarrhea-predominant irritable bowel syndrome
    Zhao, D-Y
    Qi, Q-Q
    Long, X.
    Li, X.
    Chen, F-X
    Yu, Y-B
    Zuo, X-L
    PHYSIOLOGY INTERNATIONAL, 2019, 106 (03) : 225 - 235
  • [23] Mesalamine Improve Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome
    Bafutto, Mauro
    Bafutto, Alexandre A.
    Oliveira, Enio C.
    Rezende Filho, Joffre
    GASTROENTEROLOGY, 2013, 144 (05) : S540 - S540
  • [24] The Fecal Microbiome in Children With Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Kenche, Harshavadran
    GASTROENTEROLOGY, 2010, 138 (05) : S14 - S14
  • [25] Advancements in drug development for diarrhea-predominant irritable bowel syndrome
    Dothel, Giovanni
    Barbaro, Maria Raffaella
    Raschi, Emanuel
    Barbara, Giovanni
    De Ponti, Fabrizio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 251 - 263
  • [26] Diagnostic Yield of Testing in Diarrhea-predominant Irritable Bowel Syndrome
    Manolakis, Catherine
    Di Palma, Jack
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S490 - S490
  • [27] Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
    Bassotti, Gabrio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024,
  • [28] Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome
    Chang, Full-Young
    Lu, Ching-Liang
    Chen, Chih-Yen
    Luo, Jiing-Chyuan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (12) : 2266 - 2272
  • [29] Decreased mucosal cytokines in diarrhea-predominant irritable bowel syndrome
    Chang, L
    Anton, P
    Elliott, J
    Reinholdt, J
    Taing, P
    Mayer, E
    GASTROENTEROLOGY, 2002, 122 (04) : A552 - A552
  • [30] RIFAXIMIN IS A SAFE THERAPY FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Weinstock, Leonard B.
    Pimentel, Mark
    Heimanson, Zeev
    Lembo, Anthony
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S331 - S332